Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indiana University experience

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 702-706

  Saxman, Scott B ^a   Finch, David ^a   Gonin, René ^a   Einhorn, Lawrence H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADOLESCENT; ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031894195     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.702     Document Type: Article

References (19)

1. Einhorn LH, Richie JP, Shipley WU: in De Vita VT (ed): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1993
2. Einhorn LH, Williams SD, Loehrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-391, 1989
3. Zar J: Biostatistical Analysis (ed 2). Englewood Cliffs, NJ, Prentice-Hall, 1984, pp 138-146, 390-395
4. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
5. Armitage P, Berry G: Statistical Methods in Medical Research (ed 2). Oxford, United Kingdom: Blackwell Scientific, 1987, pp 427-433
6. Cox D: Regression models and life-tables (with discussion). J Royal Stat Soc B 34:187-220, 1972
7. Simon R: Use of regression models: Statistical aspects, in Buyse M, Staquet M, Sylvester R (eds): Cancer Clinical Trials: Methods and Practice. Oxford, United Kingdom: Oxford University Press, 1984, pp 444-466
8. Clarke LA, Pregibon D: Tree-based models, in Chambers J, Hastie TJ (eds): Statistical Models in S Pacific. Grove, CA, Wadsworth Brooks, 1992, pp 377-419
9. Einhorn LH, Donohue JP: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
10. Einhorn LH, Williams SD: Chemotherapy of disseminated testicular cancer: A random prospective study. Cancer 46:1339-1344, 1980
11. Einhorn LH, Williams SD, Troner M, et al: The role of maintenance therapy in disseminated germ cell cancer. N Engl J Med 305:727-731, 1981
12. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. New Engl J Med 316:1435-1440, 1987
13. Bosl GJ, Geller NL, Cirrincione C, et al: Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43:3403-3407, 1983
14. Medical Research Council Working Party on Testicular Tumours: Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: Results of a multicentre study. Lancet 1:8-11, 1985
15. Bosl GJ, Geller NL, Bajorin D, et al: A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6:1231-1238, 1988
16. de Wit R, Stoter G, Kaye SB, et al: Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 15:1837-1843, 1997
17. Levi J, Raghavan D, Harvey V, et al: The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. J Clin Oncol 11:1300-1305, 1993
18. Loehrer P, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group Trial. J Clin Oncol 13:470-476, 1995
19. International Germ Cell Cancer Collaborative Group: International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603, 1997